Predict your next investment

Resonea company logo
INTERNET | Internet Software & Services / Health & Wellness
resonea.com

See what CB Insights has to offer

Founded Year

2016

Stage

Unattributed - II | Alive

Total Raised

$9.19M

Last Raised

$2.37M | 1 yr ago

About Resonea

Resonea develops medical-quality sleep health and wellness tools, directly accessible to consumers, to accelerate the diagnosis and treatment of hidden sleep disorders and benefit general sleep health.

Resonea Headquarter Location

11445 E. Via Linda, Suite 2, #224

Scottsdale, Arizona, 85259,

United States

480-256-1662

Latest Resonea News

RESONEA Selected for Flinn Foundation Bioscience Entrepreneurship Program

May 1, 2020

Funding Will Support Commercialization of DROWZLE® PRO, the First FDA-Cleared Digital Home Sleep Test, and Consumer Sleep Health Platform Scottsdale, AZ – April 30, 2020 – Resonea, Inc., (“Resonea” or the “Company”) a technology company founded to create a new standard for understanding sleep and breathing and their long-term impact on health, wellness, performance, and quality of life, announced that they have been selected for membership in the Flinn Foundation Bioscience Entrepreneurship Program for 2020. The Phoenix-based Flinn Foundation operates a program that supports six early-stage companies per year with select services and $30,000 in funding through a non-profit partner as part of the Foundation’s strategic mission to build Arizona into a global leader for bioscience research and commercialization. Recipients of this competitive program are selected based on their innovation in bioscience research and creation of technological solutions such as novel medical devices. In addition to receiving non-dilutive funding of $30,000, each company participates on the Bioscience Roadmap Steering Committee and receives specialized support from a commercialization expert. Resonea has developed the DROWZLE Sleep Health Program (DSHP) to provide education, screening, condition management, and follow-up for sleep health and sleep disorders such as obstructive sleep apnea (OSA). DSHP includes DROWZLE® PRO, an FDA-cleared proprietary software and analytical algorithm for detection and monitoring of OSA. This system is deployed on consumer smartphones and is the first digital home sleep test. “We are thrilled to have the opportunity to participate in the Flinn Foundation Biopreneur program,” said Karen Underwood, MD, Chief Medical Officer and co-founder of Resonea. “Sleep breathing disorders are common, costly, dangerous and often worsen other chronic health conditions. There is a massive need for more innovative detection methods. The funding will help us to demonstrate the value of DROWZLE PRO for in-home screening of adults with suspected sleep breathing disorders, through our Early Experience Reference Sites.” Media Contact: media@resonea.com About Resonea Inc. Resonea, headquartered in Scottsdale, AZ, is a medical technology company founded to advance the science of sleep health to improve an individual’s performance, safety, and quality-of-life. Its mission is to develop medical-quality sleep diagnostic tools, to accelerate the diagnosis and treatment of often-hidden sleep disorders and improve sleep health and behaviors in those with disordered sleep. Resonea has developed DROWZLE®, a proprietary software and analytical algorithmic-based system for digital deployment via consumer smartphones and other digital media. The DROWZLE system presents a disruptive technology solution for sleep health guidance as well as medical grade screening, detection, monitoring, and measuring outcomes of obstructive sleep apnea (OSA), the most common sleep disorder, and its treatment. The system includes monitoring and engagement features that allow individuals and providers to measure effectiveness of sleep interventions over time. For more information on Resonea Inc., go to www.resonea.com

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Resonea

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Resonea is included in 6 Expert Collections, including Sleep Health & Wellness.

S

Sleep Health & Wellness

792 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

M

Medical Devices

10,505 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health & Wellness Assessment

3,183 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

W

Wellness Tech

1,201 items

We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.

D

Digital Health

10,282 items

Companies using/incorporating digital tech into health, wellness, and life science offerings. Includes cos operating within the hc, consumer health, and life science industries + tech vendors catering to them. Excludes cos exclusively focused on fitness/sports & performance

T

Telehealth

2,605 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Resonea Patents

Resonea has filed 4 patents.

The 3 most popular patent topics include:

  • Peripheral nervous system disorders
  • Peripheral nervous system
  • Implants (medicine)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/14/2018

12/1/2020

Neurophysiology, Artificial neural networks, Neuroscience, Peripheral nervous system disorders, Human female endocrine system

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/14/2018

00/00/0000

00/00/0000

00/00/0000

Grant Date

12/1/2020

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Neurophysiology, Artificial neural networks, Neuroscience, Peripheral nervous system disorders, Human female endocrine system

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Resonea Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Resonea Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.